A detailed history of Sandy Spring Bank transactions in Embecta Corp. stock. As of the latest transaction made, Sandy Spring Bank holds 8 shares of EMBC stock, worth $155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$155
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$11.46 - $16.56 $91 - $132
8 New
8 $0
Q4 2022

Feb 10, 2023

SELL
$25.29 - $35.48 $2,908 - $4,080
-115 Reduced 27.06%
310 $7,000
Q3 2022

Nov 02, 2022

BUY
$24.0 - $33.42 $9,480 - $13,200
395 Added 1316.67%
425 $12,000
Q2 2022

Jul 21, 2022

BUY
$24.78 - $33.36 $743 - $1,000
30 New
30 $1,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.12B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.